Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 271,214 shares at $40.26 ($11.0M) on 2019-08-13, disclosed to the SEC on 2019-08-13.
Open-market sale of $11.0M DCPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.26 | 93,395 | $3.8M | 34.0% |
| 2 | $40.26 | 93,395 | $3.8M | 34.0% |
| 3 | $41.33 | 29,712 | $1.2M | 11.1% |
| 4 | $41.33 | 29,712 | $1.2M | 11.1% |
| 5 | $42.90 | 25,000 | $1.1M | 9.7% |
| Total | $40.74 avg | 271,214 |
| $11.0M |
| 100% |
| Filing → |
| DCPH | SELL | 2023-01-19 | $102K | — | Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |